Pharma Foods International Co., Ltd. (TYO:2929)
861.00
-17.00 (-1.94%)
Sep 12, 2025, 3:30 PM JST
TYO:2929 Revenue
In the fiscal year ending July 31, 2025, Pharma Foods International had annual revenue of 65.26B JPY with 5.01% growth. Pharma Foods International had revenue of 18.44B in the quarter ending July 31, 2025, with 23.15% growth.
Revenue
65.26B
Revenue Growth
+5.01%
P/S Ratio
0.38
Revenue / Employee
101.65M
Employees
642
Market Cap
24.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2025 | 65.26B | 3.11B | 5.01% |
Jul 31, 2024 | 62.15B | -6.43B | -9.37% |
Jul 31, 2023 | 68.57B | 8.39B | 13.94% |
Jul 31, 2022 | 60.19B | 13.43B | 28.73% |
Jul 31, 2021 | 46.75B | 31.40B | 204.51% |
Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |